Investors in Health

We provide comprehensive support to (starting, growing) companies with a technological or marketing background. We work together on reaching growth targets and provide an infrastructure of knowledge and support where the management can tip into. This includes marketing, Financial, legal and human resource support.

Meneldor offers her customers the unique opportunity to co-invest alongside specialists, in exciting early stage Biotech and Pharma companies. A sector often considered as very risky and highly complex. Meneldor thoroughly studies the science behind her potential portfolio companies. If the science is sound, then all other key aspects; IP, medical need, addressable markets, competition, risk, management, financial needs, valuation, etc., are assessed. Only if a target company meets our selection criteria, Meneldor will invest and invite her co-investors to participate.

DOMiNO Ventures is a venture capital firm focused on investing in early-stage technology startups across Europe and North America. Founded with a mission to support innovative entrepreneurs, DOMiNO Ventures provides seed and early-stage funding to companies with disruptive technologies and scalable business models. The firm targets sectors such as software, digital media, artificial intelligence, cybersecurity, and other emerging technologies. DOMiNO Ventures aims to identify promising startups and help them achieve rapid growth through strategic investment and operational support. Beyond capital infusion, DOMiNO Ventures actively engages with portfolio companies, offering mentorship, access to networks, and guidance in areas crucial for scaling, such as market expansion and product development. This hands-on approach is designed to maximize the potential of early-stage ventures and enhance their competitiveness in the global marketplace. DOMiNO Ventures is known for its agile investment strategy and flexibility in adapting to the evolving needs of startups, aiming to create long-term value for both entrepreneurs and investors.

Vivid Ventures specializes in providing early-stage capital to innovative startups, focusing on nurturing and accelerating their growth trajectories. Based in the Netherlands, Vivid Ventures strategically invests in promising ventures across various sectors, aiming to support entrepreneurs in realizing their visions and scaling their businesses. With a commitment to fostering innovation and entrepreneurial success, Vivid Ventures offers more than just financial backing; they provide strategic guidance, access to networks, and operational support to help startups navigate the challenges of early-stage growth. By leveraging their expertise and resources, Vivid Ventures aims to contribute significantly to the development of groundbreaking technologies and solutions that drive positive impact in their respective industries and beyond.

Vang Capital operates as an early-stage, high-risk investment fund. Specializing in supporting innovative ventures, Vang Capital focuses on identifying and nurturing promising startups with high growth potential. Their investment strategy aims to provide strategic capital and operational support to help startups navigate early-stage challenges and achieve significant market traction. Vang Capital's commitment to fostering innovation and entrepreneurship underscores their role in driving forward transformative ideas and technologies.

Praesidium was founded in 2016 by a group of highly experienced European and American professionals from international Private Equity, consulting and banking, with a shared vision to create a truly innovative model for successfully investing "thematically" in Private Markets.

Opes Italia is a Venture Capital fund that operates in the field of "impact investing". We invest in fast growing companies generating a strong social impact and we believe in the possibility of combining investment performance with positive social and environmental outcomes. We are sector agnostic and intervene mainly in the "early stage" phase of the development of a company.

Operational Holding Company scouting, investing and supporting high growth potential early stage companies committed to develop Healthcare Innovation. We have a key strategy focus on MedTech industry and Medical Technologies – medical devices, equipment, digital devices and services – which can provide benefit and value for Patients, Doctors and Healthcare Systems and reward Shareholders with a sound and ethical profit .

XGEN Venture is an Italian alternative investment fund manager (Società di Gestione del Risparmio, or SGR) established in 2021 by the former Genextra team, with over 15 years of activity and significant experience in the startup process, the discovery and the development of novel solutions for high unmet medical needs. The XGEN team is currently investing out of its first fund, XGEN Venture Life Science Fund launched at the end of 2022, while it continues to advise Genextra’s board of directors on the management of its portfolio.

Ada Ventures is a venture capital firm dedicated to discovering and funding exceptional talent that is tackling some of society's most challenging problems with breakthrough ideas. They specialize in investing in early-stage companies led by visionary founders who are innovating across various sectors. Ada Ventures aims to drive positive societal impact through strategic investments and support for startups that are addressing critical issues. By nurturing and empowering innovative entrepreneurs, Ada Ventures plays a pivotal role in fostering sustainable solutions to global challenges.

Deep Ocean Capital (DOC) is an indipendent management company hosting Deep Blue Ventures, a Venture Capital fund investing in Deep Technologies. DOC was born in Rome with international/global ambitions, and is focused on AI for Aerospace and Health sectors. We are early stage venture capital investors. We love technology as a means to transform our planet for the better. We believe in co-creating economic value together with the ecosystem we are part of. Deep Blue Ventures is the first VC fund of DOC, it is an early stage deep tech fund, investing in outstanding deep technologies, and people able to harnessing them to great global success. Deep Blue Ventures investments are focused in that stage where companies find product- market fit to the point where they start to scale, across multiple industry sectors where market opportunities are clearly at international scale.

Pente Capital Ltd., registered under the laws of the United Kingdom (company number 14278501), positions itself as a Venture Studio dedicated to investing in and accelerating businesses with the potential to create a positive future. As a Venture Studio, Pente Capital likely adopts a hands-on approach, providing not only financial investment but also strategic guidance, operational support, and access to networks to foster growth and success for the businesses they invest in.